|1.||Matsuki, Akira: 3 articles (03/2009 - 01/2005)|
|2.||Igawa, Akihiko: 3 articles (03/2009 - 01/2005)|
|3.||Nakadate, Teruo: 3 articles (03/2009 - 01/2005)|
|4.||Inoue, Hiroshi: 3 articles (03/2009 - 01/2005)|
|5.||Nozawa, Takashi: 3 articles (03/2009 - 01/2005)|
|6.||Fujii, Nozomu: 3 articles (03/2009 - 01/2005)|
|7.||Igarashi, Norio: 3 articles (03/2009 - 01/2005)|
|8.||Inoue, Minoru: 2 articles (01/2005 - 09/2002)|
|9.||Bachawal, Sunitha: 1 article (04/2015)|
|10.||Pu, Kanyi: 1 article (04/2015)|
11/01/2006 - "Beta-adrenoceptor blockade did not affect a visual assessment of the autoradiographic image of 9MPA in hearts subjected to ischemia-reperfusion, but it accelerated the clearance of 9MPA in both the IR and non-IR. "
01/01/2005 - "Oxidation of 9MPA was recovered 14 d after 15 min of ischemia in association with normalization of tracer uptake in IR, whereas both uptake and oxidation of 9MPA were markedly impaired 3 d after 15 min of ischemia, accompanied by slow clearance of myocardial tracer. "
03/06/2009 - "Three days after ischemia-reperfusion, FA metabolism was evaluated in rats with or without IPC using (131)I- and (125)I-15-(p-iodophenyl)-9-methylpentadecanoic acid (9MPA) and thin-layer chromatography. "
01/01/2005 - "9MPA metabolites processed via beta-oxidation were lower in the ischemic region (IR) than in non-IR 3 d after 5 min of ischemia, despite no reduction of tracer uptake in IR. "
01/01/2005 - "Using a fatty acid tracer of (131)I- and (125)I-labeled 15-(p-iodophenyl)-9-methylpentadecanoic acid (9MPA), the myocardial uptake and metabolites were determined by dual-tracer autoradiography and thin-layer chromatography in rats 3 or 14 d after reperfusion following 5 or 15 min of ischemia induced by coronary artery ligation. "
|2.||Myocardial Ischemia (Ischemic Heart Diseases)
05/01/2002 - "To evaluate the relationship between the reversible defect of 123I-15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid (9MPA) and residual viability within an infarct-related area, we performed resting single photon emission computed tomography (SPECT) with 9MPA and positron emission tomography (PET) with 18F-deoxyglucose (FDG) and 13N-ammonia (NH3) in 7 patients with prior myocardial infarction. "
04/01/1999 - "[Myocardial distribution of iodine-123-iodophenyl-9-methyl-pentadecanoic acid (9MPA) in patients with acute myocardial infarction: comparison with regional wall motion obtained from technetium-99m-sestamibi gated SPECT]."
04/10/2015 - "In vivo, as the pressures increased from 1.7 to 6.9MPa, the amount of nanoparticles deposited in cancer xenografts was increased from 4- to 14-fold, and the median penetration depth of extravasated nanoparticles was increased from 1.3-fold to 3-fold, compared to control conditions without ultrasound, as examined on 3D confocal microscopy. "
|5.||Coronary Artery Disease (Coronary Atherosclerosis)
|1.||Technetium Tc 99m Sestamibi (Cardiolite)
|1.||Heterologous Transplantation (Xenotransplantation)